Viewpoint

Genentech Should Let Us See Its Herceptin Documentary

Genentech Should Let Us See Its Herceptin Documentary

The 2009 documentary offers a wealth of detail. Which is why it makes no sense that Genentech doesn't want you to see the damn thing.

From Volume to Value, What's Next for Healthcare

From Volume to Value, What's Next for Healthcare

Pharma and biotech can bolster their value through the analytics efforts of their health economics and outcomes teams.

Pharma Marketers Using Programmatic, Consider Privacy and Measurement

Pharma Marketers Using Programmatic, Consider Privacy and Measurement

There's a reason pharma lags on the programmatic adoption curve: It's a heavily regulated industry, and there are concerns around privacy.

The Highly Regulated Healthcare Industry Can Draw in Top Marketers

The Highly Regulated Healthcare Industry Can Draw in Top Marketers

Today's ambitious marketers and media people want to be the ones to not only figure out how to work within the regulations but also to create better work than ever before.

Allowing Off-Label Data Would Do More to Protect Public Health

Allowing Off-Label Data Would Do More to Protect Public Health

We should make off-label research publicly available in a non-promotional format to both healthcare professionals and patients.

Trump or Clinton? Either May Lead to Better Mental Healthcare

Trump or Clinton? Either May Lead to Better Mental Healthcare

Despite political rifts that have blocked progress on so many other fronts, Congress has managed to lay the groundwork for clear steps forward in mental health.

Adding Support at the Point of Care May Also Improve Access to Docs

Adding Support at the Point of Care May Also Improve Access to Docs

It's becoming less and less likely that an in-person physician/sales rep interaction will take place at the healthcare provider's office.

To Move the Needle on Gender Parity, Execs Must Admit Bias

To Move the Needle on Gender Parity, Execs Must Admit Bias

I was successful because I learned how business gets done, and that often meant learning to act like one of the guys.

Hacking Healthcare: Will It Help the Patient?

Hacking Healthcare: Will It Help the Patient?

The power of hackathons is now magnified because of the power of the internet and social media, giving both patients and healthcare professionals a global platform for their voices.

Patient Listening: Is Pharma Doing It Right?

Patient Listening: Is Pharma Doing It Right?

Imagine if the agencies pitching us mocha lattes faced these consumer beliefs: The latte will hurt when I drink it. The latte might leave me with a rash or cause me to vomit.

Creativity in Healthcare: A Shift in Focus or a Better Lens?

Creativity in Healthcare: A Shift in Focus or a Better Lens?

It's time for meetings that revolve around rosé on the Carlton Terrace. It's also time for the professional creative inferiority complex to pop up for people who make pharma ads.

No More 'Patient-Centric,' Please

No More 'Patient-Centric,' Please

Maybe it's time for pharma and healthcare marketers to put all the "patient-centric" talk on the shelf — not the actual paying-attention-to-patients part of it, but the trumpeting of it as the most noble of life-science virtues.

Finding the Right Time to Talk to Doctors

Finding the Right Time to Talk to Doctors

Time is everything, yet no one has enough of it. But especially in healthcare marketing, time and timing win customers.

Shkreli's Actions Result in Broader Industry Upshot

Shkreli's Actions Result in Broader Industry Upshot

Exactly how does the erosion of public trust in the goodwill of the pharma industry impact the work being done to raise awareness and also market medicines? It's hard to tell, so far.

My Orphan Drug Awakening

My Orphan Drug Awakening

One conversation with a real patient—followed by many more conversations with more patients—helped me see how important our work can be in the eyes of patients.

OPINION

Newsletters